Evaluation of a water-soluble contrast protocol for small bowel obstruction: A southwestern surgical congress multicenter trial

Am J Surg. 2019 Dec;218(6):1046-1051. doi: 10.1016/j.amjsurg.2019.09.031. Epub 2019 Sep 30.

Abstract

Differentiation between SBO that will resolve with supportive measures and those requiring surgery remains challenging. WSC administration may be diagnostic and therapeutic. The purpose of this study was to evaluate use of a SBO protocol using WSC challenge. A protocol was implemented at five tertiary care centers. Demographics, prior surgical history, time to operation, complications, and LOS were analyzed. 283 patients were admitted with SBO; 13% underwent immediate laparotomy; these patients had a median LOS of 7.5 days. The remaining 245 were candidates for WSC challenge. Of those, 80% received contrast. 139 (71%) had contrast passage to the colon. LOS in these patients was 4 days. Sixty-five patients (29%) failed contrast passage within 24 h and underwent surgery. LOS was 9 days. 8% of patients in whom contrast passage was observed at 24 h nevertheless subsequently underwent surgery. 4% of patients who failed WSC challenge did not proceed to surgery. Our multicenter trial revealed that implementation of a WSC protocol may facilitate early recognition of partial from complete obstruction.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adult
  • Contrast Media / administration & dosage*
  • Diatrizoate Meglumine / administration & dosage*
  • Female
  • Humans
  • Intestinal Obstruction / diagnostic imaging*
  • Intestinal Obstruction / surgery*
  • Intestine, Small*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Tomography, X-Ray Computed*

Substances

  • Contrast Media
  • Diatrizoate Meglumine